Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||||||||||
| Revenue [abstract] | ||||||||||||||||||
| Revenue from rendering of services |
21.217.087
EUR
|
— | — | — | — |
430
EUR
|
— | — | — | — |
18.764.494
EUR
|
— | — | — | — |
319
EUR
|
— | — |
| Revenue |
24.217.548
EUR
|
— | — | — | — |
9.778.750
EUR
|
— | — | — | — |
22.098.155
EUR
|
— | — | — | — |
5.951.353
EUR
|
— | — |
| Material income and expense [abstract] | ||||||||||||||||||
| Finance income (cost) |
697
EUR
|
— | — | — | — |
7.379.481
EUR
|
— | — | — | — |
1.862.281
EUR
|
— | — | — | — |
2.023.328
EUR
|
— | — |
| Miscellaneous other operating expense |
30
EUR
|
— | — | — | — |
30
EUR
|
— | — | — | — |
20
EUR
|
— | — | — | — |
20
EUR
|
— | — |
| Revenue and other operating income |
21.393.899
EUR
|
— | — | — | — |
440
EUR
|
— | — | — | — |
18.771.194
EUR
|
— | — | — | — |
331
EUR
|
— | — |
| Operating expense |
14.495.918
EUR
|
— | — | — | — |
1.676.158
EUR
|
— | — | — | — |
14.083.999
EUR
|
— | — | — | — |
1.100.683
EUR
|
— | — |
| Expenses by nature [abstract] | ||||||||||||||||||
| Raw materials and consumables used |
4.120.348
EUR
|
— | — | — | — |
394
EUR
|
— | — | — | — |
4.438.174
EUR
|
— | — | — | — |
349
EUR
|
— | — |
| Classes of employee benefits expense [abstract] | ||||||||||||||||||
| Employee benefits expense |
892
EUR
|
— | — | — | — |
892
EUR
|
— | — | — | — |
457
EUR
|
— | — | — | — |
457
EUR
|
— | — |
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||||||||||||||||||
| Depreciation and amortisation expense [abstract] | ||||||||||||||||||
| Depreciation and amortisation expense |
8.710.874
EUR
|
— | — | — | — |
84
EUR
|
— | — | — | — |
8.439.108
EUR
|
— | — | — | — |
50
EUR
|
— | — |
| Other expenses, by nature |
728
EUR
|
— | — | — | — |
277
EUR
|
— | — | — | — |
729
EUR
|
— | — | — | — |
225
EUR
|
— | — |
| Expenses, by nature |
16.190.891
EUR
|
— | — | — | — |
1.810.459
EUR
|
— | — | — | — |
15.956.948
EUR
|
— | — | — | — |
1.381.140
EUR
|
— | — |
| Disclosure of attribution of expenses by nature to their function [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||||||||||||||||||
| Disclosure of attribution of expenses by nature to their function [line items] | ||||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||||||||||
| Share of profit (loss) of associates accounted for using equity method |
1.825.240
EUR
|
— | — | — | — |
1.825.240
EUR
|
— | — | — | — |
3.316.295
EUR
|
— | — | — | — |
3.316.295
EUR
|
— | — |
| Share of profit (loss) of joint ventures accounted for using equity method |
1.825.240
EUR
|
— | — | — | — |
1.825.240
EUR
|
— | — | — | — |
3.316.295
EUR
|
— | — | — | — |
3.316.295
EUR
|
— | — |
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||||||||||
| Comprehensive income |
6.662.872
EUR
|
6.662.872
EUR
|
0
EUR
|
0
EUR
|
0
EUR
|
7.966.161
EUR
|
0
EUR
|
0
EUR
|
0
EUR
|
0
EUR
|
5.474.728
EUR
|
0
EUR
|
0
EUR
|
5.474.728
EUR
|
0
EUR
|
4.591.875
EUR
|
0
EUR
|
0
EUR
|